
### [NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899)
**Label:** Secondary Prostate Urothelial Carcinoma

**Subclasses:** 

**Class expressions from DL-Learner:**

- [UBERON:0001255](http://purl.obolibrary.org/obo/UBERON_0001255) (urinary bladder) 58.33%
- [NCIT:C9334](http://purl.obolibrary.org/obo/NCIT_C9334) (Malignant Bladder Neoplasm) 58.33%
- [NCIT:C6783](http://purl.obolibrary.org/obo/NCIT_C6783) (Transitional Cell Neoplasm) 58.33%
- [NCIT:C4912](http://purl.obolibrary.org/obo/NCIT_C4912) (Bladder Carcinoma) 58.33%
- [NCIT:C41444](http://purl.obolibrary.org/obo/NCIT_C41444) (Secondary Lesion) 58.33%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 58.33%
- [NCIT:C4030](http://purl.obolibrary.org/obo/NCIT_C4030) (Urothelial Carcinoma) 58.33%
- [NCIT:C39852](http://purl.obolibrary.org/obo/NCIT_C39852) (Urothelial Neoplasm) 58.33%
- [NCIT:C39851](http://purl.obolibrary.org/obo/NCIT_C39851) (Bladder Urothelial Carcinoma) 58.33%
- [NCIT:C2930](http://purl.obolibrary.org/obo/NCIT_C2930) (Transitional Cell Carcinoma) 58.33%
- [NCIT:C2901](http://purl.obolibrary.org/obo/NCIT_C2901) (Bladder Neoplasm) 58.33%
- [NCIT:C2900](http://purl.obolibrary.org/obo/NCIT_C2900) (Bladder Disorder) 58.33%
- [UBERON:0004120](http://purl.obolibrary.org/obo/UBERON_0004120) (mesoderm-derived structure) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 58.33%
- [UBERON:0002075](http://purl.obolibrary.org/obo/UBERON_0002075) (viscus) and [UBERON:0004120](http://purl.obolibrary.org/obo/UBERON_0004120) (mesoderm-derived structure) and [UBERON:0018707](http://purl.obolibrary.org/obo/UBERON_0018707) (bladder organ) 58.33%
- Thing 51.96%


